UBS AG (UBS)
| Sector: | Financials |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.066% |
| Hold Price * : | $34.78 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q1  2026 | |||||
| ≡ | Dodge & Cox Funds | Reduce 0.06% | 20,700 | 0.00 | |
| ≡ | Richard Pzena - Pzena Investment Management | Reduce 10.85% | 3,230,218 | 0.32 | |
| ≡ | Viking Global Investors | Sell 100.00% | 9,128,817 | 1.14 | |
| Q4  2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 21.05% | 8,976,100 | 0.22 | |
| ≡ | Viking Global Investors | Reduce 30.30% | 3,967,743 | 0.50 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 20.89% | 313,523 | 0.56 | |
| Q3  2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 6.56% | 2,994,500 | 0.07 | |
| ≡ | Richard Pzena - Pzena Investment Management | Reduce 3.74% | 1,155,919 | 0.12 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 22.54% | 436,790 | 0.72 | |
| Q2  2025 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 5.16% | 105,414 | 0.16 | |
| ≡ | Dodge & Cox Funds | Reduce 37.15% | 26,972,850 | 0.51 | |
| Q1  2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 1.21% | 888,250 | 0.02 | |
| ≡ | Richard Pzena - Pzena Investment Management | Reduce 0.81% | 239,498 | 0.02 | |
| Q4  2024 | |||||
| ≡ | Richard Pzena - Pzena Investment Management | Reduce 3.94% | 1,212,143 | 0.11 | |
| Q3  2024 | |||||
| ≡ | Dodge & Cox Funds | Reduce 0.10% | 70,800 | 0.00 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.34% | 6,918 | 0.01 | |
| ≡ | Viking Global Investors | Sell 100.00% | 5,186,506 | 0.59 | |
| Q2  2024 | |||||
| ≡ | Dodge & Cox Funds | Reduce 2.63% | 1,980,700 | 0.03 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 13.29% | 310,963 | 0.49 | |
| Q1  2024 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 4.53% | 111,037 | 0.17 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Sell 100.00% | 4,809,753 | 4.02 | |
| Q4  2023 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 1.28% | 31,675 | 0.05 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 46.55% | 4,188,922 | 3.50 | |
| Q3  2023 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 0.23% | 5,653 | 0.01 | |
| Q2  2023 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 7.75% | 747,512 | 0.42 | |
| ≡ | Bill Miller - Miller Value Partners | Sell 100.00% | 1,178,255 | 1.57 | |
| Q1  2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 10,761 | 0.00 | |
| Q4  2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 82.43% | 50,472 | 0.00 | |
| Q3  2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 9.05% | 6,096 | 0.00 | |
| Q3  2018 | |||||
| ≡ | David Tepper - Appaloosa Management | Sell 100.00% | 6,828,480 | 1.22 | |
| Q2  2018 | |||||
| ≡ | David Tepper - Appaloosa Management | Reduce 1.82% | 126,919 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.